European Leukodystrophy Association   Report issue

Academic/Hospital Phase 2 Phase 4
Founded: Laxou France (1992)

Organization Overview

First Clinical Trial
2008
NCT01303146
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now

Alternative names

European Leukodystrophy Association